Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vive
San Sebastian, Gipuzkoa, Spain
- Ownership
- Private
- Employees
- ~140
- Development stage
- Other
01
Overview
VIVEbiotech is a GMP CDMO exclusively focused on lentiviral vector development and manufacturing for ex vivo gene‑modified cell therapies and in vivo gene therapies, serving >50 global biotech and pharma clients from research through clinical and commercial supply, operating under EMA and FDA standards, with a proprietary plug‑and‑play platform and non‑integrative LENTISOMA technology.[3][4][5][7]
- Therapeutic areas
- HematologyRare DiseasesOncology
- Modalities
- Gene therapyCell therapyViral vectorLentiviral vector
- Industry
- Contract Manufacturing Organization
Beyond the preview
Go deeper on Vive.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Vive.